570 Wh kg⁻1-Grade Lithium Metal Pouch Cell with 4.9V Highly Li+ Conductive Armor-Like Cathode Electrolyte Interphase via Partially Fluorinated Electrolyte Engineering
© 2024 Wiley‐VCH GmbH.
Veröffentlicht in: | Advanced materials (Deerfield Beach, Fla.). - 1998. - 36(2024), 24 vom: 13. Juni, Seite e2401505 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , |
Format: | Online-Aufsatz |
Sprache: | English |
Veröffentlicht: |
2024
|
Zugriff auf das übergeordnete Werk: | Advanced materials (Deerfield Beach, Fla.) |
Schlagworte: | Journal Article cathode electrolyte interphase high‐voltage batteries lithium metal batteries lithium‐rich manganese‐based oxides partially fluorinated electrolyte |
Zusammenfassung: | © 2024 Wiley‐VCH GmbH. Lithium-rich manganese-based layered oxides (LRMOs) are promisingly used in high-energy lithium metal pouch cells due to high specific capacity/working voltage. However, the interfacial stability of LRMOs remains challenging. To address this question, a novel armor-like cathode electrolyte interphase (CEI) model is proposed for stabilizing LRMO cathode at 4.9 V by exploring partially fluorinated electrolyte formulation. The fluoroethylene carbonate (FEC) and tris (trimethylsilyl) borate (TMSB) in formulated electrolyte largely contribute to the formation of 4.9 V armor-like CEI with LiBxOy and LixPOyFz outer layer and LiF- and Li3PO4-rich inner part. Such CEI effectively inhibits lattice oxygen loss and facilitates the Li+ migration smoothly for guaranteeing LRMO cathode to deliver superior cycling and rate performance. As expected, Li||LRMO batteries with such electrolyte achieve capacity retention of 85.7% with high average Coulomb efficiency (CE) of 99.64% after 300 cycles at 4.8 V/0.5 C, and even obtain capacity retention of 87.4% after 100 cycles at higher cut-off voltage of 4.9 V. Meanwhile, the 9 Ah-class Li||LRMO pouch cells with formulated electrolyte show over thirty-eight stable cycling life with high energy density of 576 Wh kg-1 at 4.8 V |
---|---|
Beschreibung: | Date Revised 13.06.2024 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
ISSN: | 1521-4095 |
DOI: | 10.1002/adma.202401505 |